Alburo, Clifford T.

HRN: 21-81-04  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2022
CEFTRIAXONE 1G (VIAL)
08/12/2022
08/18/2022
IVT
2gms
Q24
Acute Pyelonephritis, R/o Nephrolithiasia
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: